Target intelligence / Profile preview

RNA, U4 small nuclear 14, pseudogene (RNU4-14P)

Target
RNU4-14P
Molecular classification
Other (snRNA pseudogene)
01

Overview

**RNA, U4 small nuclear 14, pseudogene (RNU4-14P)** is annotated as a pseudogene of U4 small nuclear RNA. U4 small nuclear RNAs are genuine components of the spliceosome, the large ribonucleoprotein machinery responsible for pre-mRNA splicing in eukaryotes[2]. However, as a "pseudogene," RNU4-14P does **not encode a functional RNA product and is not known to participate in biological pathways**. Pseudogenes are generally regarded as non-functional relics derived from once-functional genes, often lacking regulatory regions or carrying disabling mutations. There is no evidence that RNU4-14P serves as a therapeutic target, disease biomarker, or is implicated in any drug interactions. Therefore, **RNU4-14P is not considered a valid molecular target, and its annotation in any context implying therapeutic or functional relevance is likely incorrect**. **Additional context:** - Some confusion may arise because functional U4 small nuclear RNAs (such as those encoded by RNU4-2 or related genes) are indeed critical for pre-mRNA splicing and disruptions in their function are disease-associated (particularly with neurodevelopmental disorders)[1][3]. Pseudogenes like RNU4-14P, however, lack such relevance because they do not produce the corresponding active RNA molecule. - If a therapeutic, regulatory, or disease association involving U4 snRNA is intended, one should refer to functional genes like RNU4-2, not RNU4-14P[1][3]. **Summary:** RNU4-14P is a non-functional pseudogene and not a valid therapeutic or biological target. If the query was meant to refer to the active U4 small nuclear RNA (such as encoded by RNU4-2), please clarify for the appropriate canonical entry.

Other names
RNU4-14P

Beyond the preview

Go deeper on RNA, U4 small nuclear 14, pseudogene (RNU4-14P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 14, pseudogene (RNU4-14P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call